NATICK, Mass., Nov. 15, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) commends the leadership of Senator Al Franken (D-MN), Senator Lamar Alexander (R-TN) and Senator John Kerry (D-MA) for their introduction today of the Patient Access to Medical Innovation Act in the U.S. Senate.

The legislation is a thoughtful and well-timed effort to address the concerns of medical device manufacturers and patients alike.  It seeks to improve the ability of companies like Boston Scientific to safely, efficiently and predictably bring new technologies to market.  The bill also recognizes the importance of safeguarding patient access to these life-enhancing and life-saving innovations.

Boston Scientific looks forward to working with the Senators and other Members of Congress on these and other issues that will incentivize device innovation that is critical for patient health and well-being.

About Boston Scientific

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties.  For more information, please visit: www.bostonscientific.com.  

SOURCE Boston Scientific Corporation